JP2020512375A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020512375A5 JP2020512375A5 JP2019553504A JP2019553504A JP2020512375A5 JP 2020512375 A5 JP2020512375 A5 JP 2020512375A5 JP 2019553504 A JP2019553504 A JP 2019553504A JP 2019553504 A JP2019553504 A JP 2019553504A JP 2020512375 A5 JP2020512375 A5 JP 2020512375A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- peptide
- cancer
- epitope
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762477895P | 2017-03-28 | 2017-03-28 | |
| US62/477,895 | 2017-03-28 | ||
| PCT/US2018/024831 WO2018183488A1 (en) | 2017-03-28 | 2018-03-28 | Human pd1 peptide vaccines and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020512375A JP2020512375A (ja) | 2020-04-23 |
| JP2020512375A5 true JP2020512375A5 (enExample) | 2021-05-06 |
| JP7346302B2 JP7346302B2 (ja) | 2023-09-19 |
Family
ID=63678120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019553504A Active JP7346302B2 (ja) | 2017-03-28 | 2018-03-28 | ヒトｐｄ－１ペプチドワクチン及びその使用法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11684660B2 (enExample) |
| EP (1) | EP3600398B1 (enExample) |
| JP (1) | JP7346302B2 (enExample) |
| KR (1) | KR102653567B1 (enExample) |
| CN (2) | CN118909082A (enExample) |
| AU (2) | AU2018243920B2 (enExample) |
| BR (1) | BR112019020386A2 (enExample) |
| CA (1) | CA3058393A1 (enExample) |
| ES (1) | ES2963635T3 (enExample) |
| RU (1) | RU2019131252A (enExample) |
| WO (1) | WO2018183488A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019153042A1 (en) * | 2018-02-07 | 2019-08-15 | Imugene Limited | A vaccine composition and uses thereof |
| JP7304421B2 (ja) * | 2018-10-05 | 2023-07-06 | アールエヌエージーン インコーポレイテッド | 標的細胞特異的に結合して多重免疫機能が強化されたキメラ抗原及びこの用途 |
| BR112022005044A2 (pt) * | 2019-09-17 | 2022-07-05 | Ohio State Innovation Foundation | Peptídeo quimérico, peptídeo sintético, composição farmacêutica, anticorpo, método de tratamento |
| US20260007730A1 (en) * | 2022-04-21 | 2026-01-08 | Ohio State Innovation Foundation | Human ctla-4 peptide vaccines and uses thereof |
| WO2024211745A1 (en) * | 2023-04-05 | 2024-10-10 | Ohio State Innovation Foundation | Human pd1, pd-l1, and ctla-4 combination peptide vaccines and uses thereof |
| CN119019569B (zh) * | 2024-08-19 | 2025-10-24 | 中国人民解放军陆军军医大学 | 一种可定向增强胸腺新生t细胞杀伤乳腺癌的多肽及其应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1601438A (enExample) | 1968-10-17 | 1970-08-24 | ||
| US4342566A (en) | 1980-02-22 | 1982-08-03 | Scripps Clinic & Research Foundation | Solid phase anti-C3 assay for detection of immune complexes |
| US5652138A (en) | 1992-09-30 | 1997-07-29 | The Scripps Research Institute | Human neutralizing monoclonal antibodies to human immunodeficiency virus |
| ATE183513T1 (de) | 1993-06-03 | 1999-09-15 | Therapeutic Antibodies Inc | Herstellung von antikörperfragmenten |
| WO1997038011A1 (en) * | 1996-04-03 | 1997-10-16 | Pepresearch A/S | Non-dendritic backbone peptide carrier |
| FR2765243B1 (fr) | 1997-06-30 | 1999-07-30 | Usinor | Acier inoxydable austenoferritique a tres bas nickel et presentant un fort allongement en traction |
| EP1651258B1 (en) * | 2003-07-30 | 2014-03-19 | Vaccine Research Institute of San Diego | Hepatitis virus core proteins as vaccine platforms and methods of use thereof |
| GB0400440D0 (en) * | 2004-01-09 | 2004-02-11 | Isis Innovation | Receptor modulators |
| DK2439273T3 (da) | 2005-05-09 | 2019-06-03 | Ono Pharmaceutical Co | Humane monoklonale antistoffer til programmeret død-1(pd-1) og fremgangsmåder til behandling af cancer ved anvendelse af anti-pd-1- antistoffer alene eller i kombination med andre immunterapeutika |
| AU2006261342B2 (en) * | 2005-06-15 | 2012-02-02 | The Ohio State University Research Foundation | Her-2 peptides |
| HUE032379T2 (en) * | 2007-07-27 | 2017-09-28 | Immatics Biotechnologies Gmbh | Composition of tumour-associated peptides and related anti-cancer vaccine |
| AU2009274568A1 (en) * | 2008-07-25 | 2010-01-28 | The Regents Of The University Of Colorado | Proteins for use in diagnosing and treating infection and disease |
| US20100234283A1 (en) * | 2009-02-04 | 2010-09-16 | The Ohio State University Research Foundation | Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use |
| US8907053B2 (en) * | 2010-06-25 | 2014-12-09 | Aurigene Discovery Technologies Limited | Immunosuppression modulating compounds |
| NZ713461A (en) * | 2011-04-15 | 2017-02-24 | Compugen Ltd | Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancer |
| IN2014KN00920A (enExample) * | 2012-06-21 | 2015-10-09 | Compugen Ltd | |
| US9381244B2 (en) * | 2012-09-07 | 2016-07-05 | King's College London | VISTA modulators for diagnosis and treatment of cancer |
| WO2014161509A1 (en) | 2013-04-05 | 2014-10-09 | The University Of Hong Kong | Novel pd1 isoforms, and uses thereof for potentiating immune responses |
| CN105377897A (zh) * | 2013-05-03 | 2016-03-02 | 俄亥俄州创新基金会 | Cs1-特异性嵌合抗原受体工程化的免疫效应细胞 |
| TWI676636B (zh) | 2013-07-12 | 2019-11-11 | Ｖｌｐ醫療股份有限公司 | 包含ｐｄ－１抗原或ｐｄ－１配體抗原的類病毒粒子 |
| US9969986B2 (en) | 2014-08-08 | 2018-05-15 | Vlp Therapeutics, Llc | Virus like particle comprising modified envelope protein E3 |
| PT3177640T (pt) * | 2014-08-08 | 2020-08-31 | Univ Leland Stanford Junior | Agentes pd-1 de alta afinidade e métodos de utilização |
| DK3237446T3 (en) * | 2014-12-22 | 2021-07-26 | Pd 1 Acquisition Group Llc | Anti-PD-1-antistoffer |
-
2018
- 2018-03-28 ES ES18778305T patent/ES2963635T3/es active Active
- 2018-03-28 EP EP18778305.5A patent/EP3600398B1/en active Active
- 2018-03-28 CN CN202410999144.6A patent/CN118909082A/zh active Pending
- 2018-03-28 WO PCT/US2018/024831 patent/WO2018183488A1/en not_active Ceased
- 2018-03-28 CN CN201880022159.XA patent/CN110636855B/zh active Active
- 2018-03-28 RU RU2019131252A patent/RU2019131252A/ru unknown
- 2018-03-28 CA CA3058393A patent/CA3058393A1/en active Pending
- 2018-03-28 KR KR1020197031158A patent/KR102653567B1/ko active Active
- 2018-03-28 BR BR112019020386-9A patent/BR112019020386A2/pt active Search and Examination
- 2018-03-28 JP JP2019553504A patent/JP7346302B2/ja active Active
- 2018-03-28 US US16/498,929 patent/US11684660B2/en active Active
- 2018-03-28 AU AU2018243920A patent/AU2018243920B2/en active Active
-
2025
- 2025-03-11 AU AU2025201760A patent/AU2025201760A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020512375A5 (enExample) | ||
| RU2019131252A (ru) | Пептидные вакцины на основе pd1 человека и их применение | |
| ES2966473T3 (es) | Derivados de camptotecina | |
| CN110300601B (zh) | 吡咯并苯并二氮杂䓬-抗体缀合物 | |
| CN110267686B (zh) | 吡咯并苯并二氮杂䓬-抗体缀合物 | |
| TWI712423B (zh) | 抗ｔｒｏｐ２抗體-藥物結合物之製造方法 | |
| JP2023510905A5 (enExample) | ||
| JP2025114615A (ja) | 治療薬としての細胞毒素のペプチドコンジュゲート | |
| JP2020505955A5 (enExample) | ||
| JP2016518382A (ja) | Ａｘｌ抗体薬物複合体および癌の治療のためのその使用 | |
| JP2023505708A5 (enExample) | ||
| TW202146057A (zh) | 半胱胺酸工程改造抗體之結合物 | |
| RU2009149462A (ru) | АНТИТЕЛА ПРОТИВ NRR Notch1 И СПОСОБЫ ИХ ПРИМЕНЕНИЯ | |
| JP2010531140A5 (enExample) | ||
| HRP20180262T1 (hr) | Monoklonska anti-gt468 protutijela za liječenje karcinoma | |
| CN108601952B (zh) | 雷公藤内酯的葡萄糖缀合物、类似物及其用途 | |
| CA2560278A1 (en) | Modified bouganin proteins, cytotoxins and methods and uses thereof | |
| JP2023519261A5 (enExample) | ||
| JP2021508714A (ja) | ベンゾジアゼピン誘導体 | |
| JP2019530707A (ja) | イソキノリジノベンゾジアゼピン（ｉｑｂ）−１（クロロメチル）−２，３−ジヒドロ−１ｈ−ベンゾ［ｅ］インドール（ｃｂｉ）二量体 | |
| JP2022548364A5 (enExample) | ||
| JP2020535811A5 (enExample) | ||
| JP2022518150A5 (enExample) | ||
| WO2025035706A1 (zh) | 一种抗体金纳米笼载药系统、制备方法和用途 | |
| JP2019519536A5 (enExample) |